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Abstract
Objective: Depressive symptoms have been associated with Type 2 diabetes, but the temporal
direction of this association and the underlying mechanisms remain unclear. The present study
examined a potential, bidirectional association between depressive symptoms and glucose
levels in women and men, and the factors mediating this association. Methods: The
participants were from the Cardiovascular Risk in Young Finns Study, a prospective,
population-based, cohort study (n = 2534). Depressive symptoms were assessed using a
modified Beck Depression Inventory. Fasting glucose was measured concurrently with
depressive symptoms. To analyze the data, a multiple-group cross-lagged analysis and parallel
multiple mediation in structural equation modeling were used. Results: Depressive symptoms
in 2001 were positively associated with glucose levels in 2012 in women (β = .07, p = .023)
but not in men (β = −.03, p = .45). This sex difference was statistically significant (p = .042).
Glucose levels in 2001 did not predict depressive symptoms in 2012 in either women or men
(ps = .96). Changes in body mass index, high-sensitivity C-reactive protein, alcohol
consumption, or tobacco or cigarette smoking did not mediate the observed association (ps >
.05). Conclusions: The results showed a positive association between depressive symptoms
and glucose levels in women but not in men. The direction of this relationship seems to be
from depressive symptoms to glucose levels rather than the reverse. Changes in body fat,
inflammation, alcohol consumption, or tobacco or cigarette smoking may not play a
mediating role in this observed association.
Keywords: depressive symptoms, fasting glucose, hyperglycemia, sex differences, Type
2 diabetes mellitus
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Is the Association Between Depressive Symptoms and Glucose Bidirectional? A Population-Based
Study
The prevalence of clinical depression (Nichols & Brown, 2003) and depressive
symptoms has been shown to be higher in individuals with Type 2 diabetes compared with in
the general population (Anderson, Freedland, Clouse, & Lustman, 2001). Despite the fact that
the co-occurrence of symptoms of depression and Type 2 diabetes has attracted much research
interest, the temporal direction of this association and the underlying mechanisms remain
unclear (Tabák, Akbaraly, Batty, & Kivimäki, 2014). If depressive symptoms do increase the
risk of Type 2 diabetes, or vice versa, the association between these two conditions should
already be observed with metabolic changes that precede diabetes onset, such as elevated
glucose concentrations. Thus, chronically increased glucose levels may be one of the
plausible mechanisms that accounts for the reported, positive relationship between depressive
symptoms and Type 2 diabetes.
Most previous research of the association between depressive symptoms and
hyperglycemia has been based on cross-sectional data (Kivimaki et al., 2009; Mezuk et al.,
2013; Nouwen et al., 2011), which cannot address the temporal direction of the association,
whereas evidence from longitudinal studies (Akbaraly et al., 2013; Eriksson et al., 2008;
Georgiades et al., 2007; Golden et al., 2008; Hamer, Batty, & Kivimaki, 2011) has provided
inconsistent results. A Swedish prospective, population-based study (Eriksson et al., 2008)
suggested that hyperglycemia might be a mechanism through which depressive symptoms
could contribute to Type 2 diabetes development in men. These results were not supported by
a quasi-experimental study, performed  in a clinical sample of U.S. patients with diabetes
(Georgiades et al., 2007), which reported that changes in depressive symptoms are not
associated with changes in glycemia over a 1-year period. On the other hand, the English
Longitudinal Study of Aging examining the role of poor glucose metabolism in the
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development of depressive symptoms (Hamer et al., 2011) showed that hyperglycemia can be
a causal risk factor for depressive mood, especially in men. Findings from the Whitehall II
Study (Akbaraly et al., 2013) documented, however, no association between elevated glucose
levels and subsequent depressive symptoms in either women or men. Similarly, the Multi-
Ethnic Study of Atherosclerosis (Golden et al., 2008) also suggested that chronic
hyperglycemia is unlikely to be a mechanism underlying the link between Type 2 diabetes
and depressive symptoms.
Elevated glucose could lead to depressive symptoms through several pathways. First,
chronic hyperglycemia has been shown to elicit such symptoms associated with negative
mood as fatigue and difficulty with concentration (Adriaanse et al., 2005). Further, elevated
glucose levels can influence the development of macrovascular and microvascular
complications that may have biological effects which could, either individually or
collectively, increase the risk of depressive symptoms (Egede, 2005). Another possible
pathway is that higher glucose concentrations can activate pro-inflammatory mechanisms
(Stuart & Baune, 2012) implicated in the reduction of neuroplasticity (Calabrese et al., 2014),
which, in turn, has been associated with depression (Lee & Kim, 2010).
Plausible mechanisms through which depressive symptoms could directly influence
hyperglycemia include biological alterations in the sympathetic nervous system (SNS) and the
hypothalamic-pituitary-adrenal axis (HPA axis; Brown, Varghese, & McEwen, 2004;
Krishnan & Nestler, 2008), and immune dysregulation and activation of the inflammatory
response system (Esser, Legrand-Poels, Piette, Scheen, & Paquot, 2014; Kiecolt-Glaser,
Derry, & Fagundes, 2015). These two mechanisms have not, however, consistently been
linked to an increased risk of Type 2 diabetes (Tabák et al., 2014).
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Depressive symptoms could also lead to elevated glucose levels indirectly by worsening
adherence to healthy diet (Alhazmi, Stojanovski, McEvoy, & Garg, 2014; Lin et al., 2004)
and physical activity (Jeon, Lokken, Hu, & van Dam, 2007; van Gool et al., 2003). Other
possible pathways through which depressive symptoms could contribute to disturbed
glycemia include excess body fat (Ganz et al., 2014; Luppino et al., 2010) and an increase in
health-risk behaviors, such as alcohol consumption (Kao, Puddey, Boland, Watson, &
Brancati, 2001; Wang & Patten, 2001) and smoking (Maddatu, Anderson-Baucum, & Evans-
Molina, 2017; van Gool et al., 2003). So far, the effect of depressive symptoms on health
behaviors and the impact of depression-related behaviors on the risk of Type 2 diabetes have
only been examined in isolation in previous non-clinical studies. Thus, the mediating role of
behavioral factors in the association between depressive symptoms and hyperglycemia
remains uncertain.
Establishing the temporal ordering in the association between depressive symptoms and
glucose levels, and the mechanisms underlying this relationship would provide valuable
information on the nature of the association between depressive symptoms and Type 2
diabetes. Thus, the first aim of our prospective, population-based, cohort study was to
investigate the direction of the association between depressive symptoms and glucose
concentrations in women and men. This relationship was tested using three repeated
measurements of depressive symptoms and fasting glucose (years: 2001, 2007, and 2012).
The model with two repeated surveys (the time lapse of 11 years from 2001 to 2012) was the
primary model, while the model with three time points (6- and 5-year time lag from 2001 to
2007 and from 2007 to 2012) was tested additionally. This was due to the fact that the
potential association between depressive symptoms and glucose levels, or plausible sex
differences in this relationship were more likely to be observed within a longer time lapse,
given that our study was based on a relatively young population (before the peak age of the
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onset for Type 2 diabetes). The second objective of the present study was to examine whether
changes in body fat, inflammation, alcohol consumption, or tobacco or cigarette smoking
mediate the association between depressive symptoms and glucose levels.
Methods
Participants
The participants were from the Cardiovascular Risk in Young Finns Study, an ongoing,
prospective, population-based study, which has examined risk factors underlying
cardiovascular diseases in the Finnish population (Raitakari et al., 2008). The study has been
conducted in all Finnish cities with a medical school (Helsinki, Kuopio, Oulu, Tampere, and
Turku) and their rural surroundings. A randomized sample of 3596 healthy Finnish children
and adolescents (both boys and girls) aged 3, 6, 9, 12, 15, and 18 years has been followed
since 1980 (the baseline study). Thereafter, eight follow-up studies have been performed in
1983, 1986, 1989, 1992, 1997, 2001, 2007, and 2012. The study was approved by the ethics
committee of each of the five participating universities (i.e., University of Helsinki,
University of Kuopio, University of Oulu, University of Tampere, and University of Turku).
The participants’ written informed consent was obtained.
The present study was based on the data from the 2001, 2007, and 2012 follow-ups. To
be included in the first part of the statistical analysis, the participants had to have information
on either depressive symptoms or glucose concentrations in 2001 or 2012, and information on
socioeconomic status (SES) in 2001 (n = 2560). Those individuals who in 2001 had Type 1
diabetes or Type 2 diabetes were excluded (n = 26). Thus, the final sample consisted of 2534
participants (70.5% of the original sample).
In the second part of the statistical analysis (additional analysis), the participants with
information on either depressive symptoms or glucose levels in at least one measurement
point (2001, 2007, or 2012), and information on SES in 2001 were included (n = 2572).
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Individuals with Type 1 diabetes or Type 2 diabetes in 2001 were excluded (n = 23).
Therefore, the analytic sample comprised 2549 participants (70.9% of the original sample).
The mediation analysis was conducted only in women. Those female participants who
had information on at least one of the variables being a part of the tested model and who did
not have the diagnosis of Type 1 diabetes or Type 2 diabetes in 2001 were included in this
analysis (n = 1820).
The attrition analysis, which were conducted using multilevel mixed-effects logistic
regression (QR decomposition) with three measurement points, showed that higher glucose
levels (OR = 18.57, 95% CI [4.42, 77.90], p < .001), lower SES (OR = 2.45, 95% CI [1.84,
3.27], p < .001), and female sex (OR = 3.97, 95% CI [2.95, 5.36], p < 0.001) predicted greater
drop-out. Older age was associated with lower attrition (OR = 0.94, 95% CI [0.91, 0.97], p <
.001). Higher depressive symptoms did not predict drop-out (OR = 1.07, 95% CI [0.86, 1.34],
p = .54). With regard to the pattern of missing values, 1934 (64.0%) participants had data on
either depressive symptoms or glucose in all three waves, 284 (9.4%) in 2001, 272 (9.0%) in
2001 and 2007, 200 (6.6%) in 2007 and 2012, 137 (4.5%) in 2001 and 2012, 108 (3.6%) in
2007, and 89 (2.9%) in 2012.
Measures
Depressive symptoms. Depressive symptoms were assessed in 2001, 2007, and 2012
using a modified version of the Beck Depression Inventory (BDI-I; Beck & Steer, 1987),
which was translated into Finnish and adopted for use in the Cardiovascular Risk in Young
Finns Study (Elovainio et al., 2015; Katainen, Raikkonen, Keskivaara, & Keltikangas-
Jarvinen, 1999). The original version of the instrument consists of 21 items with four
alternative response options for each item, representing increasing levels in the intensity of
depressive symptoms, e.g., 0 = I do not feel sad, 1 = I feel sad, 2 = I am sad all the time and I
can’t snap out of it, and 3 = I am so sad and unhappy that I can’t stand it. In the modified
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version of the BDI-I, the participants are asked to rate the second mildest statement of each
item of the original BDI-I (in the above example, this would be option 1 = I feel sad) on a 5-
point Likert scale ranging from totally disagree (1) to totally agree (5). These second mildest
statements were selected for the modified measure as they were expected to better capture a
wider range of variation in milder depressive tendencies within the general population
compared with the original version of the scale (Katainen, Räikkönen, & Keltikangas-
Järvinen, 1999). They also made the inventory easier to fill out, and thus, less-time consuming
(Katainen, Räikkönen, & Keltikangas-Järvinen, 1999), since the participants indicated their
level of agreement with one statement instead of the need to review four separate statements
of each item in order to choose one of them. A severity score of depressive symptoms was
calculated as the mean score of responses. Internal consistency coefficient (Cronbach’s α) as
an indicator of reliability of the scale was .92 in 2001, and .93 in 2007 and 2012. The
modified BDI-I has been shown to be correlated with the Beck Depression Inventory-II (BDI-
II), a measure designed to screen for depressive disorder, with the coefficient .77 (Rosenström
et al., 2012). The validity of the scale has also been demonstrated through its correlations with
psychosocial characteristics known to be associated with depressive symptoms, including
negative emotionality and low sociability (Katainen, Räikkönen, & Keltikangas-Järvinen,
1999), fatigability and sentimentality (Elovainio et al., 2004), hostility and low levels of
perceived social support (Heponiemi et al., 2006), or emotional reactivity and perseveration
(Hintsa et al., 2016).
Fasting glucose. Fasting serum glucose concentrations were measured in 2001, 2007,
and 2012 with the enzymatic hexokinase method (Glucose reagent, Beckman Coulter
Biomedical) using an Olympus AU400 instrument (Olympus, Tokyo, Japan). Due to the fact
that the distribution of glucose levels was significantly skewed to the right (positive
skewness), glucose values were log transformed in the main analysis.
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Potential confounders. All the statistical analysis was adjusted for the potential,
confounding effects of baseline age and SES as the two variables have been associated with
both depressive symptoms and Type 2 diabetes (Everson, Maty, Lynch, & Kaplan, 2002;
Sutin et al., 2013; Wild, Roglic, Green, Sicree, & King, 2004). SES was measured as an
educational level. The categories were as follows: high (graduated from or studying at a
university, or graduated from a polytechnic institution); intermediate (secondary education: a
high school (three degrees) or a vocational school (three degrees) as the highest degree); and
low (a primary school (nine degrees) or less as the highest level of education).
Potential mediators. Information on body fat, inflammation, alcohol consumption, and
tobacco or cigarette smoking was collected in 2001 and 2007. Body mass index (BMI) was
used as an indicator of body fat. It was calculated as weight (kg) / height2 (m2). Height was
measured with a wall-stated stadiometer and weight was measured with Seca scales.
Inflammation was defined by levels of serum high-sensitivity C-reactive protein (hs-CRP),
which were measured using an automated analyzer (Olympus AU400, Olympus, USA) and a
highly sensitive turbidimetric immunoassay kit (CRP-UL-assay, Wako Chemicals, Neuss,
Germany). The frequency of alcohol consumption was assessed with one question (number of
occasions per week when at least six units of alcoholic beverages are consumed within one
day) having six alternative responses (1 = twice a week or more often, 2 = once a week, 3 =
twice or three times a month, 4 = once a month, 5 = twice to six times a year, and 6 = rarely
or never). The frequency of current tobacco or cigarette smoking was measured by one
question with five alternative answers (1 = I smoke once a day or more often, 2 = I smoke
once a week or more often but not every day, 3 = I smoke less than once a week, 4 = I quit
smoking, and 5 = I have never smoked). Alcohol intake and tobacco or cigarette smoking were
recoded so that higher values indicated higher frequency.
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Statistical Analysis
To test the direction of the association between depressive symptoms and glucose levels
in women and men, and to assess whether there would be sex differences in the obtained path
coefficients, multiple-group cross-lagged path analysis in structural equation modeling (SEM)
was performed (first, with data from 2001 and 2012, and then, additionally, with data from all
the three measurement points, i.e., 2001, 2007, and 2012). Parallel multiple mediation in SEM
was used to examine whether changes in BMI, hs-CRP, alcohol consumption, or tobacco or
cigarette smoking (from 2001 to 2007) mediate the association between depressive symptoms
(2001) and glucose levels (2012). The model was adjusted for baseline age and SES, and the
baseline values of the mediators of interest and glucose levels. Indirect effects were tested by
calculating confidence intervals (normal-based 95% CI) using bootstrapping with 1000
repetitions; this procedure has been recommended in assessing indirect effects in multiple
mediator models (Preacher & Hayes, 2008).
Goodness-of-fit of the SEM models was evaluated based on: the chi-squared test (χ2),
the root mean squared error of approximation (RMSEA), the comparative fit index (CFI), and
the Tucker-Lewis Index (TLI). A non-significant χ2 value indicates that the model is a good
fit to the data (Acock, 2013). This index is, however, highly sensitive to sample size,
especially when the number of observations is greater than 200 (Hoe, 2008). RMSEA values
of less than .05 and .08 indicate a good and a reasonable fit, respectively (Acock, 2013).
Nevertheless, this measure has been shown to often falsely indicate poor fitting in models
with small degrees of freedom, especially in those with a very small sample size (Kenny,
Kaniskan, & McCoach, 2015). For CFI and TLI, values above .90 and .95 represent an
acceptable and a good fit, respectively (Acock, 2013).
The comparison of the models with regard to their fit was conducted by computing the
difference in χ2 test (Δχ2). If the Δχ2 was significant at p < .05 (Byrne, 2001), a model with
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more freely estimated parameters was accepted as being a better fit to the data than a model in
which fewer parameters were estimated.
To avoid biased results due to missing data, the main analyses were performed using the
full information maximum likelihood estimation (FIML; Dong & Peng, 2013). In this
approach, all available data (both from complete and incomplete cases) are utilized during
parameter estimation. The FIML obtains parameter estimates by maximizing the likelihood
function of the incomplete data. The method produces unbiased estimates when data are
missing completely at random or missing at random. Due to the fact that this assumption is
not testable, pattern mixture modeling (PMM) was applied to deal with non-ignorable (i.e.,
informative) drop-out (Dantan, Proust-Lima, Letenneur, & Jacqmin-Gadda, 2008). In this
method, a covariate characterizing the participants’ drop-out pattern is created and included in
the analysis as a potentially confounding variable. The attrition indicator in the present study
was based on the number of follow-ups in which the participant took part (i.e., had data on
either depressive symptoms or glucose). Since this variable provided information for the
purpose of missing at random estimation, the drop-out did not need to be ignorable. The
moderating effect of the attrition indicator on the associations of interest was not included in
the multiple-group cross-lagged models as neither interaction effect of the attrition indicator
and glucose on depressive symptoms (p = .68) nor interaction effect of the attrition indicator
and depressive symptoms on glucose (p = .39) was observed when fitting regression models
to panel data (“xtreg”).
The differences between women and men in the study variables were tested with the t-
test and the Mann-Whitney U test. All the statistical analyses were performed using
STATA/SE 13 software.
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Results
Table 1 shows the characteristics of the participants included in the first part of the
statistical analysis (multiple-group cross-lagged analysis with two measurement points). In
2001, women had higher SES and scored higher than men on depressive symptoms.
Compared with women, men had higher glucose concentrations in 2001 and 2012. Women
and men did not differ in age and depressive symptoms measured in 2012.
------------------------------------------------------------
Insert Table 1 here
------------------------------------------------------------
In the model adjusted for baseline age and SES, equality constraints were imposed on
paths that were not statistically different between women and men (i.e., paths b and d, ps >
.05; Figure 1). The model fit difference between this model and the saturated unconstrained
model (with all coefficients allowed to vary across sex) was non-significant (Δχ2 (2) = 0.28, p
= .87), suggesting that the former (i.e., more parsimonious) should be retained. When the
retained model and the fully constrained model were compared, the model fit difference was
significant (Δχ2 (2) = 9.94, p = .007), which indicated that the partially constrained model
(i.e., less parsimonious) should be selected.
------------------------------------------------------------
Insert Figure 1 here
------------------------------------------------------------
Figure 1 and Table 2 present the results of the final model. The model was a good fit to
the data (χ2 (2) = 0.28, RMSEA = .00, CFI = 1.00, TLI = 1.01). Depressive symptoms
predicted glucose levels in women (β = .07, p = .023) but not in men (β = −.03, p = .45). This
sex difference was statistically significant (p = .042). Glucose levels, however, did not predict
subsequent depressive symptoms in either women (β = .00, p = .96) or men (β = .00, p = .96).
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------------------------------------------------------------
Insert Table 2 here
------------------------------------------------------------
Additionally, multiple-group cross-lagged analysis with three measurement points
controlling for baseline age and SES was performed. The model in which all the paths were
allowed to vary across sex did not provide a satisfactory fit to the data (χ2 (8) = 154.61,
RMSEA = .12, CFI = .95, TLI = 0.83). To significantly improve the fit, a correlation between
depressive symptoms in 2001 and depressive symptoms in 2012 (path l) was added to the
equation (χ2 (6) = 52.62, RMSEA = .08, CFI = .99, TLI = 0.93; Figure 2). This model showed
that only paths b and c were statistically different between women and men (ps < .05).
Further, path e was found to be significant in women but not in men, although this difference
was non-significant (p > .05). When equality constraints were imposed on all the paths except
paths b, c, and e, the model fit difference between this new model (χ2 (14) = 67.13, RMSEA =
.06, CFI = .98, TLI = 0.97) and the fully unconstrained model was non-significant (Δχ2 (8) =
14.51, p = .069). Thus, the model with equality constraints (i.e., more parsimonious) was
selected. Thereafter, the model fit difference between this partially constrained model and a
fully constrained model was tested. The results showed that the difference was significant
(Δχ2 (3) = 13.15, p = .004), suggesting that the former model should be retained.
------------------------------------------------------------
Insert Figure 2 here
------------------------------------------------------------
The results of the final model are shown in Figure 2 and Supplemental Table 1.
Depressive symptoms in 2001 predicted glucose levels in 2007 in women (β = .06, p = .027)
but not in men (β = .02, p = .61). As above-mentioned, this sex difference was non-significant
(p = .32). There was no association going from depressive symptoms in 2007 to glucose
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concentrations in 2012 in either women (β = −.01, p = .56) or men (β = −.01, p = .56).
Furthermore, glucose levels did not predict depressive symptoms in either sex (years 2001-
2007: β = .01, p = .51 in women and β = .01, p = .51 in men; years 2007-2012: β = .02, p =
.42 in women and β = .01, p = .42 in men).
Mediation analysis
Further analysis was performed only in women among whom the association from
depressive symptoms to glucose levels was found. Descriptive statistics of the female
participants included in this analysis are presented in Supplemental Table 2. The results of the
parallel multiple mediation adjusted for baseline age and SES, and the baseline scores of the
tested mediators and glucose levels are presented in Table 3. The model was a good fit to the
data (χ2 (22) = 193.99, RMSEA = .07, CFI = .95, TLI = 0.89). Neither the total indirect effect
(β = .01, b = 0.00, 95% CI [−0.00, 0.01], p = .13) nor the specific indirect effects (BMI: β =
.01, b = 0.00, 95% CI [−0.00, 0.00], p = .15; hs-CRP: β = −.00, b = −0.00, 95% CI [−0.00,
0.00], p = .83; alcohol intake: β = .00, b = 0.00, 95% CI [−0.00, 0.00], p = .46; and tobacco or
cigarette smoking: β = .00, b = 0.00, 95% CI [−0.00, 0.00], p = .85) were statistically
significant.
------------------------------------------------------------
Insert Table 3 here
------------------------------------------------------------
Discussion
To our knowledge, this is the first study, which examined a bidirectional association
between depressive symptoms and glucose concentrations in women and men, and the factors
mediating this relationship. First, the results from our prospective, population-based, cohort
study showed that depressive symptoms in 2001 were positively associated with glucose
levels in 2007 and 2012 in women but not in men. Depressive symptoms in 2007 did not,
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however, predict glucose concentrations in 2012 in either sex. Thus, it is possible that the
experience of depressive symptoms especially at the beginning of the fourth decade of life
may be an important risk factor for the development of Type 2 diabetes in women. Further,
the observed sex difference in the association going from depressive symptoms to glucose
levels reached statistical significance within an 11- but not a 6-year time lag, suggesting that
the difference between women and men in this relationship may develop over a longer time
period. The study also found that glucose levels in 2001 did not predict depressive symptoms
in 2007 or 2012 and that glucose concentrations in 2007 were not associated with depressive
symptoms in 2012 in either women or men. Moreover, depressive symptoms and glucose
levels were shown to be moderately stable over time, which could be driven by the influence
of genetic factors and the relative stability of demographic, lifestyle, and environmental
factors, such as socioeconomic position (Carvalho, 2012), dietary patterns (Johns et al., 2014),
or physical activity (Telama et al., 2014). Finally, our findings suggested that the association
from depressive symptoms to glucose levels may not be mediated by changes in BMI, hs-
CRP, alcohol intake, or tobacco or cigarette smoking.
Contrary to the conclusion of the latest literature review (Tabák et al., 2014), our study
supported the notion that symptoms of depression can directly increase the risk of Type 2
diabetes by showing that depressive symptoms were positively associated with glucose levels.
As changes in hs-CRP did not mediate the studied association, chronic inflammation is
unlikely to be a mechanism underlying the direct effect of depressive symptoms on disturbed
glucose homeostasis. It is, however, possible that biological changes induced by depressive
symptoms, such as dysfunctions in the HPA axis and the SNS, which were not examined in
the present study, could play a mediating role in the link between depressive symptoms and
hyperglycemia.
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Moreover, our research showed that the association between depressive symptoms and
glucose concentrations was not mediated by changes in BMI, alcohol intake, or tobacco or
cigarette smoking. This is not in line with the results of a previous study (Chiu, Wray,
Beverly, & Dominic, 2010), which suggested that depressive symptoms may affect glycemia
indirectly by changes in BMI and smoking. Given, however, that this study did not control for
the baseline values of glucose levels and was based on a clinical sample of individuals
diagnosed with Type 2 diabetes, the full causal pathways linking depressive symptoms to
hyperglycemia could not have been established. Thus, our investigation added considerably to
the current evidence base.
In our study, the association going from depressive symptoms to glucose concentrations
was observed in women but not in men. These results are in agreement with the finding from
cross-sectional research of the Hoorn Study (Adriaanse et al., 2008), which suggested a sex
interaction, with an enhanced risk of prediabetes and Type 2 diabetes in depressed women but
not in men. In contrast to the present investigation, a Swedish longitudinal, population-based
study (Eriksson et al., 2008) documented an increased risk of prediabetes and Type 2 diabetes
in men with psychological distress (i.e., symptoms of anxiety, apathy, depression, fatigue, and
insomnia) but not in women (except for prediabetes in the middle index group of distress).
This inconsistency could result from the fact that the measure of distress in the Swedish study
consisted of only five items, suggesting low reliability of the instrument.
Sex differences in coping mechanisms in response to stress/depressive symptoms could
be one of the plausible explanations for the presence of the positive association between
depressive symptoms and glucose levels in women but not in men. Women and men have
been shown to differ in styles of coping with distress (Mikolajczyk, El Ansari, & Maxwell,
2009; Piccinelli & Wilkinson, 2000; Tamres, Janicki, & Helgeson, 2002) that might
contribute to differential diabetes risk factors. For example, men have a tendency to engage in
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physical and instrumental activities to overcome their depressed mood, whereas women tend
to become less physically active and engage in more ruminative thinking (Piccinelli &
Wilkinson, 2000; Tamres et al., 2002) that maintains their depressive state (Nolen-Hoeksema,
2000). In addition, stress and depressive symptoms may lead to the adoption of an unhealthy
diet (i.e., more frequent consumption of sweets/fast food and less frequent consumption of
fruits and vegetables) in women but not in men (Mikolajczyk et al., 2009). These sex
differences in adherence to exercise and healthy diet could further result in an increased risk
for the development of Type 2 diabetes (Alhazmi et al., 2014; Jeon et al., 2007) among
women but not among men.
The present study supports the conclusion of a recent literature review (Tabák et al.,
2014) that pathophysiological changes associated with Type 2 diabetes, including increased
glucose concentrations, might not cause depressive symptoms. Our findings are also
consistent with the results of the Whitehall II Study (Akbaraly et al., 2013), which showed
that elevated fasting glucose levels (treated as a continuous variable) do not increase the risk
depressive symptoms in either sex. Additionally, in line with the present findings, the U.S.
Multi-Ethnic Study of Atherosclerosis (Golden et al., 2008) found an increased risk of
depressive symptoms in individuals with treated Type 2 diabetes—but a decreased risk in
those with prediabetes and untreated Type 2 diabetes (prediabetes and diabetes status was
defined by fasting glucose concentrations), providing evidence that chronically elevated
glucose levels may not contribute to depressive symptoms. However, our results are not in
accordance with the findings from the English Longitudinal Study of Aging (Hamer et al.,
2011), which revealed that elevated glucose levels (indicated by a measure of glycated
hemoglobin, HbA1C) can increase the risk of depressive symptoms, especially in men. The
discrepancy might be due to different methods used to measure glucose concentrations, since
the same study also found that Type 2 diabetes (when defined using both HbA1C and fasting
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glucose), and prediabetes (when defined using HbA1C but not fasting glucose) are associated
with an increased risk of depressive symptoms. Similarly, cross-sectional data from the
Hertfordshire Cohort Study (Holt et al., 2009) showed a positive association of depressive
symptoms with glycemia in women and men when glucose concentrations were measured
with 2-hour post-load glucose but not with fasting glucose.
Some methodological limitations of our study need to be taken into account when
interpreting the results. First, depressive symptoms were self-reported, therefore some
reporting bias could occur. Second, the present study did not sample clinically depressed
individuals but people with depressive symptoms in the general population. Therefore, future
studies need to focus on testing the association of glucose levels with clinically diagnosed
depression in order to replicate our findings. Third, the study was based on a relatively young
population (age range of 35 to 50 years in the latest follow-up, M = 42.54). Given that the
number of people diagnosed with Type 2 diabetes starts to increase rapidly in midlife (Wild et
al., 2004), it is possible that our results provided an underestimate of the magnitude of the
association between depressive symptoms and glucose levels among older people. Thus, it is
advisable that the present study is reproduced in older populations. Further, the measurement
of glucose concentrations was based on a single test of fasting glucose. Since there is some
evidence which suggests that fasting glucose may be a less robust and reliable diagnostic tool
for Type 2 diabetes than 2-hour post-load glucose (Pomerleau, McKeigue, & Chaturvedi,
1999) or HbA1C (Bonora & Tuomilehto, 2011), we recommend that future research could
incorporate these two other measures of glycemia, in addition to fasting glucose, to verify our
findings. Moreover, BMI might not have accurately reflected the changes in body fat of our
participants. Research using more direct measures of adiposity is warranted to confirm that
overweight or obesity are unlikely to mediate the association between depressive symptoms
and hyperglycemia. In addition, our investigation did not take into account cumulative
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exposure to excess body fat, inflammation, or health-risk behaviors, therefore the mediating
role of these factors might have been underestimated. In further studies, this aspect is
important to be considered. Finally, the potential mediating effect of dietary patterns and
physical activity on the association between depressive symptoms and glucose levels was not
tested in the present research. Thus, future studies are needed to examine the role of those
factors in the relationship of interest.
The present study has a number of strengths. The inclusion of a young population can
be seen not only as a limitation but also as a strength. Knowledge about whether depressive
symptoms predict glucose concentrations before the peak age of the onset for Type 2 diabetes
is valuable for better understanding the temporal course of the development of diabetes, and
thus, for assuring the timely implementation of appropriate preventive interventions for this
disease. Most previous studies of the association between depressive symptoms and glucose
levels were conducted on older populations, therefore our study makes an important
contribution to this field of research. Further, the use of three repeated measurements of
depressive symptoms and fasting glucose, treated as continuous variables, over a long period
of time (i.e., 11 years) and within the same population-based and large sample enabled to
make more precise inference about the direction of the association between depressive
symptoms and glucose levels. Moreover, the analysis was performed considering sex-specific
differences. The current study also explored the mediating factors of the association from
depressive symptoms to glucose levels. Finally, the use of the FIML estimation helped to
produce results that are unlikely to be biased by attrition.
Conclusions
The results showed that there is a positive association between depressive symptoms
and glucose levels in women but not in men. The direction of this relationship seems to be
from depressive symptoms to glucose levels rather than the reverse. Furthermore, the effect of
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depressive symptoms on glucose levels may not be mediated by changes in body fat,
inflammation, alcohol intake, or cigarette or tobacco smoking. Given this, health care
professionals should be aware that women with elevated depressive symptoms may have
elevated glucose levels, and thus may be at elevated risk for developing Type 2 diabetes.
Future studies, in particular randomized clinical trials, are needed to assess whether the
initiation of routine screening for depressive symptoms (which can include referral to mental
health specialists) among women already at the beginning of the fourth decade of life could be
of value in preventing glucose abnormalities.
The present results do not exclude the possibility that the association in the direction of
Type 2 diabetes leading to depressive symptoms can be attributable to psychosocial stress
caused by the diagnosis of Type 2 diabetes, the burden of treatment, and complications related
to this disease (Tabák et al., 2014). Thus, routine screening for depressive symptoms in all
patients diagnosed with Type 2 diabetes, as recommended by the American Association of
Clinical Endocrinologists (Handelsman et al., 2015) and the Canadian Diabetes Association
(Robinson, Luthra, & Vallis, 2013), should continue to be performed.
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Table 1
Characteristics of the Study Participants by Sex
Study variables
Women Men
n (%) M (SD) n (%) M (SD) p-value for a difference
Sex 1406 (55.5) 1128 (44.5)
Age in 2001 (years) 1406 31.53 (4.97) 1128 31.55 (5.00) .91
SES in 2001 1406 1128 .063
   Low 126 (9.0) 97 (8.6)
   Intermediate 885 (62.9) 762 (67.6)
   High 395 (28.1) 269 (23.9)
Depressive symptoms in 2001 1152 2.16 (0.66) 823 2.01 (0.58) < .001
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Depressive symptoms in 2007a 1090 2.13 (0.65) 722 2.02 (0.59) < .001
Depressive symptoms in 2012 913 2.08 (0.64) 627 2.05 (0.63) .39
Glucose in 2001 (mmol/l) 1242 4.87 (0.44) 1007 5.15 (0.42) < .001
Glucose in 2007 (mmol/l)b 1093 5.15 (0.59) 843 5.43 (0.51) < .001
Glucose in 2012 (mmol/l) 1002 5.22 (0.77) 785 5.50 (0.70) < .001
Note. M = mean; n = number of participants; SD = standard deviation.
a, bThe variable used in the cross-lagged model with three measurement points.
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Table 2
The Results of the Multiple-Group Cross-Lagged Analysis With Two Measurement Points (2001 and 2012) Testing for Sex





b 95% CI p-value b 95% CI p-value p-value for a difference
Depressive symptoms 2012
Depressive symptoms 2001 0.57 [0.52, 0.62] < .001 0.68 [0.61, 0.75] < .001 .015
   Glucose 2001 0.01 [−0.32, 0.34] .96 0.01 [−0.32, 0.34] .96 -
Glucose 2012
   Glucose 2001 0.52 [0.46, 0.58] < .001 0.52 [0.46, 0.58] < .001 -
   Depressive symptoms 2001 0.01 [0.00, 0.02] .024 −0.00 [−0.02, 0.01] .45 .042
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Note. b = unstandardized linear regression coefficient; CI = confidence interval; n = number of participants. The model fitted with
logarithmically transformed glucose values adjusting for baseline age and SES.
Table 3
The Results of the Parallel Multiple Mediation Analysis in Women (n = 1820)
Direct effect Indirect effect Total effect
Outcome β p-value β p-value β p-value
BMI
   Depressive symptoms -> BMI .03 .13 .03 .13
hs-CRP
   Depressive symptoms -> hs-CRP −.01 .81 −.01 .81
Alcohol intake
   Depressive symptoms -> Alcohol intake .02 .43 .02 .43
Tobacco or cigarette smoking
   Depressive symptoms -> Smoking .02 .30 .02 .30
Glucose
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   Depressive symptoms -> Glucosea .04 .21 .01 .13 .05 .12
      Depressive symptoms -> BMI -> Glucoseb .01 .15
      Depressive symptoms -> hs-CRP -> Glucosec −.00 .83
      Depressive symptoms -> Alcohol intake -> Glucosed .00 .46
      Depressive symptoms -> Smoking -> Glucosee .00 .85
   BMI -> Glucose .39 < .001 .39 < .001
   hs-CRP -> Glucose .03 .44 .03 .44
   Alcohol intake -> Glucose .08 .025 .08 .025
   Tobacco or cigarette smoking -> Glucose .01 .85 .01 .85
Note. β = standardized linear regression coefficient. The model fitted with logarithmically transformed glucose values and adjusted
for baseline: age, SES, BMI, hs-CRP, alcohol intake, tobacco or cigarette smoking, and glucose.
aThe total of the indirect effects. b−eThe specific indirect effects.
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